Not applicableEnded earlyNCT00925405What this trial is testingBreast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyWho this might be right forBreast Cancer M.D. Anderson Cancer Center 10
Not applicableLooking for participantsNCT05705531What this trial is testingA Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin LymphomaWho this might be right forCardiovascular DisorderClassic Hodgkin LymphomaClonal Hematopoiesis Children's Oncology Group 190
Early research (Phase 1)Ended earlyNCT00848601What this trial is testingSafety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's LymphomaWho this might be right forProstate CancerNon-Hodgkins Lymphoma Astex Pharmaceuticals, Inc. 14
Not applicableStudy completedNCT04396119What this trial is testingDeveloping Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative StudyWho this might be right forHodgkin Lymphoma The Christie NHS Foundation Trust 30
Testing effectiveness (Phase 2)Looking for participantsNCT07473167What this trial is testingStudy of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma PatientsWho this might be right forRelapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more TICAROS Co., Ltd. 98
Not applicableNot Yet RecruitingNCT05343377What this trial is testingA Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell LymphomaWho this might be right forExtranodal Natural Killer/T-cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 72
Testing effectiveness (Phase 2)Study completedNCT00002501What this trial is testingCyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 29
Early research (Phase 1)Active Not RecruitingNCT06824701What this trial is testingTazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin Lymphoma University of Utah 24
Early research (Phase 1)Study completedNCT00058292What this trial is testingRadiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University 44
Not applicableStudy completedNCT00764829What this trial is testingBlood Samples to Evaluate Biomarkers of Donor ChimerismWho this might be right forLeukemiaHodgkins DiseaseNon-hodgkins Lymphoma+1 more Fred Hutchinson Cancer Center 80
Large-scale testing (Phase 3)Study completedNCT00112931What this trial is testingRituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma University College, London 462
Testing effectiveness (Phase 2)Study completedNCT02254772What this trial is testingA Phase I/II Study of Intratumoral Injection of SD-101Who this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more Robert Lowsky 9
Not applicableNot Yet RecruitingNCT07008872What this trial is testingCD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute LeukemiaWho this might be right forCD7+ LymphomaCD7+ Acute Leukemia Qi deng 40
Early research (Phase 1)Study completedNCT00867230What this trial is testingFTS Study in Patients With Advanced Hematologic MalignanciesWho this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 18
Not applicableNot Yet RecruitingNCT06827639What this trial is testingIn-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer PatientsWho this might be right forHead and Neck CancerUrologic CancerLung Cancer+2 more Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Study completedNCT04875195What this trial is testingPembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)Who this might be right forHodgkin's LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL) Merck Sharp & Dohme LLC 66
Testing effectiveness (Phase 2)Ended earlyNCT01925612What this trial is testingStudy of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)Who this might be right forLymphoma, B-cellLymphoma, Large B-cell, Diffuse Seagen Inc. 87
Not applicableStudy completedNCT03147365What this trial is testingEffect of Different Exercises on Quality of Life of Leukemia Patients.Who this might be right forQuality of LifeAcute Lymphoblastic LeukemiaExercise Children's Cancer Hospital Egypt 57357 75
Large-scale testing (Phase 3)Looking for participantsNCT06091865What this trial is testingCompare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma (DLBCL) Regeneron Pharmaceuticals 904
Testing effectiveness (Phase 2)Looking for participantsNCT05873712What this trial is testingZanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's SyndromeWho this might be right forRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaTransformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma+5 more Aseel Alsouqi 24